Notch Therapeutics Promotes Chris Bond to Chief Scientific Officer
VANCOUVER, BC — Notch Therapeutics, Inc., a biotechnology company developing renewable, induced pluripotent stem cell (iPSC)-derived cell therapies for cancer, is pleased to announce Dr. Chris Bond has been promoted to… Read More




